AL Hardaway, MK Herroon, E Rajagurubandara… - Cancer and Metastasis …, 2014 - Springer
Adipocytes are important but underappreciated components of bone marrow microenvironment, and their numbers greatly increase with age, obesity, and associated …
JY Pierga, S Delaloge, M Espié, E Brain… - Breast cancer research …, 2010 - Springer
To assess anti-tumor activity of sequential epirubicin/cyclophosphamide followed by docetaxel with the randomized addition of celecoxib in HER2 negative patients or …
Y Liu, A Kosaka, M Ikeura, G Kohanbash… - Neuro …, 2013 - academic.oup.com
Background As therapies for systemic cancer improve and patients survive longer, the risk for brain metastases increases. We evaluated whether immune mechanisms are involved in …
B Shi, X Hu, H He, W Fang - Oncology Letters, 2021 - spandidos-publications.com
Pre‑clinical and on‑going trials have indicated the advantage of using metformin as an anticancer drug alone or in combination with other chemotherapeutics for the treatment of …
K Hughes, JM Dobson - The Veterinary Journal, 2012 - Elsevier
Feline mammary tumours comprise approximately 11% of feline non-integumentary neoplasms, are more commonly malignant than benign, and carry a poor prognosis …
A Göbel, S Dell'Endice, N Jaschke, S Pählig… - International Journal of …, 2021 - mdpi.com
Tumor metastasis to bone is a common event in multiple forms of malignancy. Inflammation holds essential functions in homeostasis as a defense mechanism against infections and is …
SY Ye, JY Li, TH Li, YX Song, JX Sun, XW Chen… - Current …, 2022 - mdpi.com
The purpose of this meta-analysis was to evaluate the efficacy and safety of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, in addition to standard anticancer therapy …
HS Kim, HG Moon, W Han, CK Yom, WH Kim… - Breast cancer research …, 2012 - Springer
To determine the significance of (Cyclooxygenase 2) COX2 for clinical outcome in breast cancer, we analyzed the correlation between COX2 overexpression and survival in 687 …
V Madka, CV Rao - Current cancer drug targets, 2013 - ingentaconnect.com
Every year more than a million new cancer cases and 600,000 deaths are reported world- wide. Colorectal cancer is the fourth most commonly occurring and second leading cause of …